Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease (Q6697238)
From MaRDI portal
| This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: [[]] |
Dataset published at Zenodo repository.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease |
Dataset published at Zenodo repository. |
Statements
These data describe thebound and unbound ensembles of a disordered peptide (amyloid beta) in the presence and absence of a small, drug-like molecule. The data were produced by metadynamic metainference simulations restrained with NMR chemical shift data. We used PLUMED version 2.6.0 and GROMACS 2018.3. All the data and PLUMED input files required to reproduce the metadynamic metainference results are available on PLUMED-NEST (www.plumed-nest.org), the public repository of the PLUMED consortium, as plumID:20.014. A Jupyter Notebook describing the analysis of these results is available from GitHub at https://github.com/vendruscolo-lab/amyloid-beta_small_mol/ in Metadynamic_metainference/Analysis. These data support the findings of the manuscript entitled Small molecule sequestration of amyloid- as a drug discovery strategy for Alzheimers disease by Heller et al. DOI:10.1101/729392
0 references
8 August 2019
0 references
0.1.0
0 references